PharmaMar Launches Aplidin Quadruple Combo Trial in Myeloma
PharmaMar is launching a clinical trial to explore its investigational therapy Aplidin (plitidepsin) in a quadruple combination treatment for multiple myeloma. The four compounds involved…
Magdalena Kegel, —
Articles by Magdalena Kegel
Kyprolis-Dexamethasone Combo Allows Relapsed Myeloma Patients to Live Longer, Amgen Says
Kyprolis (carfilzomib), when given with dexamethasone, lets relapsed myeloma patients live an average 7.6 months longer than those treated with  Velcade (bortezomib) with dexamethasone — information that …
KD025 Shows Promise for Chronic Graft-Versus-Host Disease, a Common Complication of Stem Cell Transplants
Kadmon reports that the first patient group treated in a Phase 2 trial of its drug KD025 for chronic graft-versus-host disease after going through…
FDA Suspends Keytruda Combination Trials for Myeloma After Patient Deaths
The U.S. Food and Drug Administration (FDA) has ordered Merck to suspend two Phase 3 and part of a…
FDA Approves Lab Test to Help Detect Myeloma
The U.S. Food and Drug Administration (FDA) recently approved a lab test to aid in the detection and diagnosis of myeloma and a range of…
Oncology Venture Enrolls First Multiple Myeloma Patient in Clinical Trial
Oncology Venture has enrolled the first patient into a Phase 1/2 trial of its compound APO010 in multiple myeloma. Patients in the study will…
GMI-1271 Restores Velcade’s Punch Against Myeloma in Mice, Study Reports
GlycoMimetics’ GMI-1271 restored the punch of the myeloma treatment Velcade (bortezomib) in mice, which should rekindle hope in patients who failed to respond to…
Janssen to Discuss New Combinations of Darzalex and Other Multiple Myeloma Therapies
Janssen Biotech will discuss at a Chicago cancer conference the effectiveness of new multiple myeloma treatment combinations that include its therapy Darzalex (daratumumab). The…
Stem Cell Transplant with 3-Drug Combo Improved Progression-Free, But Not Overall Myeloma Survival
Treatment with Revlimid (lenalidomide), Velcade (bortezomib), and dexamethasone (RVD), in addition to a stem cell transplant, improved progression-free survival among multiple myeloma patients…
Rabbit Virus Hammers Myeloma in Mice, but Human Use Is a Ways Off
A rabbit virus slowed the growth of multiple myeloma in mice, and eradicated the cancer in a fourth of the animals, a study reported. But…
